Full test bank for
Pharmacology and the nursing process 11th edition
By linda lane lilley phd rn, shelly rainforth collins pharmd bcgp, julie s.
Snyder
All chapters 1-58 | all parts 1-10 |verified answers
,table of contents
part 1: pharmacology basics ........................................................................................................... 5
chapter 01: the nursing process and drug therapy ..................................................................... 5
chapter 02: pharmacologic principles....................................................................................... 10
chapter 03: lifespan considerations .......................................................................................... 18
chapter 04: cultural, legal, and ethical considerations ............................................................. 27
chapter 05: medication errors: preventing and responding ..................................................... 35
chapter 06: patient education and drug therapy...................................................................... 39
chapter 07: over-the-counter drugs and herbal and dietary supplements .............................. 45
chapter 08: gene therapy and pharmacogenomics .................................................................. 50
chapter 09: photo atlas of drug administration ........................................................................ 53
part 2: drugs affecting the central nervous system ...................................................................... 65
chapter 10: analgesic drugs ...................................................................................................... 65
chapter 11: general and local anesthetics ................................................................................ 74
chapter 12: central nervous system depressants and muscle relaxants .................................. 79
chapter 13: central nervous system stimulants and related drugs........................................... 86
chapter 14: antiepileptic drugs ................................................................................................. 92
chapter 15: antiparkinson drugs ............................................................................................... 99
chapter 16: psychotherapeutic drugs ..................................................................................... 106
chapter 17: substance use disorder ........................................................................................ 115
part 3: drugs affecting the autonomic nervous system .............................................................. 122
chapter 18: adrenergic drugs .................................................................................................. 122
chapter 19: adrenergic-blocking drugs ................................................................................... 128
chapter 20: cholinergic drugs ................................................................................................. 134
chapter 21: cholinergic-blocking drugs ................................................................................... 141
part 4: drugs affecting the cardiovascular and renal systems .................................................... 148
chapter 22: antihypertensive drugs ........................................................................................ 148
chapter 23: antianginal drugs ................................................................................................. 156
chapter 24: heart failure drugs ............................................................................................... 164
, chapter 25: antidysrhythmic drugs ......................................................................................... 172
chapter 26: coagulation modifier drugs.................................................................................. 179
chapter 27: antilipemic drugs ................................................................................................. 187
chapter 28: diuretic drugs ....................................................................................................... 194
chapter 29: fluids and electrolytes ......................................................................................... 202
part 5: drugs affecting the endocrine and reproductive systems ........................................... 210
chapter 30: pituitary drugs ..................................................................................................... 210
chapter 31: thyroid and antithyroid drugs .............................................................................. 214
chapter 32: antidiabetic drugs ................................................................................................ 221
chapter 33: adrenal drugs ....................................................................................................... 233
chapter 34: women’s health drugs ......................................................................................... 238
chapter 35: men’s health drugs .............................................................................................. 248
part 6: drugs affecting the respiratory system ............................................................................ 254
chapter 36: antihistamines, decongestants, antitussives, and expectorants ......................... 254
chapter 37: respiratory drugs ................................................................................................. 261
part 7: antiinfective and antiinflammatory drugs ....................................................................... 268
chapter 38: antibiotics part 1 .................................................................................................. 268
chapter 39: antibiotics part 2 .................................................................................................. 278
chapter 40: antiviral drugs ...................................................................................................... 285
chapter 41: antitubercular drugs ............................................................................................ 291
chapter 42: antifungal drugs ................................................................................................... 298
chapter 43: antimalarial, antiprotozoal, and anthelmintic drugs ........................................... 305
chapter 44: anti-inflammatory and antigout drugs ................................................................ 311
part 8: chemotherapeutic drugs and biologic and immune modifiers ....................................... 319
chapter 45: antineoplastic drugs part 1: cancer overview and cellcycle– specific drugs ....... 319
chapter 46: antineoplastic drugs part 2: cell cycle–nonspecific drugs and miscellaneous drugs
................................................................................................................................................. 326
chapter 47: biologic response–modifying and antirheumatic drugs ...................................... 333
chapter 48: immunosuppressant drugs .................................................................................. 339
chapter 49: immunizing drugs ................................................................................................ 346
,part 9: drugs affecting the gastrointestinal system and nutrition .............................................. 352
chapter 50: acid-controlling drugs .......................................................................................... 352
chapter 51: bowel disorder drugs ........................................................................................... 361
chapter 52: antiemetic and antinausea drugs ........................................................................ 371
chapter 53: vitamins and minerals.......................................................................................... 378
chapter 54: anemia drugs ....................................................................................................... 386
chapter 55: nutritional supplements ...................................................................................... 395
part 10: dermatologic, ophthalmic, and otic drugs .................................................................... 401
chapter 56: dermatologic drugs.............................................................................................. 401
chapter 57: ophthalmic drugs ................................................................................................. 410
chapter 58: otic drugs ............................................................................................................. 416
,Part 1: pharmacology basics
Chapter 01: the nursing process and drug therapy
Multiple choice
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been
newly diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
diagnosis?
A. Anxiety
B. Anxiety related to new drug therapy
C. Anxiety related to anxious feelings about drug therapy, as evidenced by statements such
as ―i‘m upset about having to test my blood sugars.‖
D. Anxiety related to new drug therapy, as evidenced by statements such as ―i‘m upset
about having to test my blood sugars.‖
Ans: d
Formulation of nursing diagnoses is usually a three-step process. ―anxiety‖ is missing the
―related to‖ and ―as evidenced by‖ portions of defining characteristics. ―anxiety related to
new drug therapy‖ is missing the ―as evidenced by‖ portion of defining characteristics. The
statement beginning ―anxiety related to anxious feelings‖ is incorrect because the ―related
to‖ section is simply a restatement of the problem ―anxiety,‖ not a separate factor related to
the response.
Dif: cognitive level: understanding (comprehension) top: nursing process: nursing diagnosis
Msc: nclex: safe and effective care environment: management of care
2. The patient is to receive oral guaifenesin (mucinex) twice a day. Today, the nurse was
busy and gave the medication 2 hours after the scheduled dose was due. What type of problem
does this represent?
A. ―right time‖
B. ―right dose‖
C. ―right route‖
D. ―right medication‖
, Ans: a
―right time‖ is correct because the medication was given more than 30 minutes after the
scheduled dose was due. ―dose‖ is incorrect because the dose is not related to the time the
medication administration is scheduled. ―route‖ is incorrect because the route is not affected.
―medication‖ is incorrect because the medication ordered will not change.
Dif: cognitive level: applying (application) top: nursing process: implementation
Msc: nclex: safe and effective care environment: safety and infection control
3. The nurse has been monitoring the patient‘s progress on a new drug regimen since the
first dose and documenting the patient‘s therapeutic response to the medication. Which phase
of the nursing process do these actions illustrate?
A. Nursing diagnosis
B. Planning
C. Implementation
D. Evaluation
Ans: d
Monitoring the patient‘s progress, including the patient‘s response to the medication, is part of
the evaluation phase. Planning, implementation, and nursing diagnosis are not illustrated by
this example.
Dif: cognitive level: understanding (comprehension) top: nursing process: evaluation
Msc: nclex: safe and effective care environment: management of care
4. The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus.
Which statement best illustrates an outcome criterion for this patient?
A. The patient will follow instructions.
B. The patient will not experience complications.
C. The patient will adhere to the new insulin treatment regimen.
Pharmacology and the nursing process 11th edition
By linda lane lilley phd rn, shelly rainforth collins pharmd bcgp, julie s.
Snyder
All chapters 1-58 | all parts 1-10 |verified answers
,table of contents
part 1: pharmacology basics ........................................................................................................... 5
chapter 01: the nursing process and drug therapy ..................................................................... 5
chapter 02: pharmacologic principles....................................................................................... 10
chapter 03: lifespan considerations .......................................................................................... 18
chapter 04: cultural, legal, and ethical considerations ............................................................. 27
chapter 05: medication errors: preventing and responding ..................................................... 35
chapter 06: patient education and drug therapy...................................................................... 39
chapter 07: over-the-counter drugs and herbal and dietary supplements .............................. 45
chapter 08: gene therapy and pharmacogenomics .................................................................. 50
chapter 09: photo atlas of drug administration ........................................................................ 53
part 2: drugs affecting the central nervous system ...................................................................... 65
chapter 10: analgesic drugs ...................................................................................................... 65
chapter 11: general and local anesthetics ................................................................................ 74
chapter 12: central nervous system depressants and muscle relaxants .................................. 79
chapter 13: central nervous system stimulants and related drugs........................................... 86
chapter 14: antiepileptic drugs ................................................................................................. 92
chapter 15: antiparkinson drugs ............................................................................................... 99
chapter 16: psychotherapeutic drugs ..................................................................................... 106
chapter 17: substance use disorder ........................................................................................ 115
part 3: drugs affecting the autonomic nervous system .............................................................. 122
chapter 18: adrenergic drugs .................................................................................................. 122
chapter 19: adrenergic-blocking drugs ................................................................................... 128
chapter 20: cholinergic drugs ................................................................................................. 134
chapter 21: cholinergic-blocking drugs ................................................................................... 141
part 4: drugs affecting the cardiovascular and renal systems .................................................... 148
chapter 22: antihypertensive drugs ........................................................................................ 148
chapter 23: antianginal drugs ................................................................................................. 156
chapter 24: heart failure drugs ............................................................................................... 164
, chapter 25: antidysrhythmic drugs ......................................................................................... 172
chapter 26: coagulation modifier drugs.................................................................................. 179
chapter 27: antilipemic drugs ................................................................................................. 187
chapter 28: diuretic drugs ....................................................................................................... 194
chapter 29: fluids and electrolytes ......................................................................................... 202
part 5: drugs affecting the endocrine and reproductive systems ........................................... 210
chapter 30: pituitary drugs ..................................................................................................... 210
chapter 31: thyroid and antithyroid drugs .............................................................................. 214
chapter 32: antidiabetic drugs ................................................................................................ 221
chapter 33: adrenal drugs ....................................................................................................... 233
chapter 34: women’s health drugs ......................................................................................... 238
chapter 35: men’s health drugs .............................................................................................. 248
part 6: drugs affecting the respiratory system ............................................................................ 254
chapter 36: antihistamines, decongestants, antitussives, and expectorants ......................... 254
chapter 37: respiratory drugs ................................................................................................. 261
part 7: antiinfective and antiinflammatory drugs ....................................................................... 268
chapter 38: antibiotics part 1 .................................................................................................. 268
chapter 39: antibiotics part 2 .................................................................................................. 278
chapter 40: antiviral drugs ...................................................................................................... 285
chapter 41: antitubercular drugs ............................................................................................ 291
chapter 42: antifungal drugs ................................................................................................... 298
chapter 43: antimalarial, antiprotozoal, and anthelmintic drugs ........................................... 305
chapter 44: anti-inflammatory and antigout drugs ................................................................ 311
part 8: chemotherapeutic drugs and biologic and immune modifiers ....................................... 319
chapter 45: antineoplastic drugs part 1: cancer overview and cellcycle– specific drugs ....... 319
chapter 46: antineoplastic drugs part 2: cell cycle–nonspecific drugs and miscellaneous drugs
................................................................................................................................................. 326
chapter 47: biologic response–modifying and antirheumatic drugs ...................................... 333
chapter 48: immunosuppressant drugs .................................................................................. 339
chapter 49: immunizing drugs ................................................................................................ 346
,part 9: drugs affecting the gastrointestinal system and nutrition .............................................. 352
chapter 50: acid-controlling drugs .......................................................................................... 352
chapter 51: bowel disorder drugs ........................................................................................... 361
chapter 52: antiemetic and antinausea drugs ........................................................................ 371
chapter 53: vitamins and minerals.......................................................................................... 378
chapter 54: anemia drugs ....................................................................................................... 386
chapter 55: nutritional supplements ...................................................................................... 395
part 10: dermatologic, ophthalmic, and otic drugs .................................................................... 401
chapter 56: dermatologic drugs.............................................................................................. 401
chapter 57: ophthalmic drugs ................................................................................................. 410
chapter 58: otic drugs ............................................................................................................. 416
,Part 1: pharmacology basics
Chapter 01: the nursing process and drug therapy
Multiple choice
1. The nurse is writing a nursing diagnosis for a plan of care for a patient who has been
newly diagnosed with type 2 diabetes. Which statement reflects the correct format for a nursing
diagnosis?
A. Anxiety
B. Anxiety related to new drug therapy
C. Anxiety related to anxious feelings about drug therapy, as evidenced by statements such
as ―i‘m upset about having to test my blood sugars.‖
D. Anxiety related to new drug therapy, as evidenced by statements such as ―i‘m upset
about having to test my blood sugars.‖
Ans: d
Formulation of nursing diagnoses is usually a three-step process. ―anxiety‖ is missing the
―related to‖ and ―as evidenced by‖ portions of defining characteristics. ―anxiety related to
new drug therapy‖ is missing the ―as evidenced by‖ portion of defining characteristics. The
statement beginning ―anxiety related to anxious feelings‖ is incorrect because the ―related
to‖ section is simply a restatement of the problem ―anxiety,‖ not a separate factor related to
the response.
Dif: cognitive level: understanding (comprehension) top: nursing process: nursing diagnosis
Msc: nclex: safe and effective care environment: management of care
2. The patient is to receive oral guaifenesin (mucinex) twice a day. Today, the nurse was
busy and gave the medication 2 hours after the scheduled dose was due. What type of problem
does this represent?
A. ―right time‖
B. ―right dose‖
C. ―right route‖
D. ―right medication‖
, Ans: a
―right time‖ is correct because the medication was given more than 30 minutes after the
scheduled dose was due. ―dose‖ is incorrect because the dose is not related to the time the
medication administration is scheduled. ―route‖ is incorrect because the route is not affected.
―medication‖ is incorrect because the medication ordered will not change.
Dif: cognitive level: applying (application) top: nursing process: implementation
Msc: nclex: safe and effective care environment: safety and infection control
3. The nurse has been monitoring the patient‘s progress on a new drug regimen since the
first dose and documenting the patient‘s therapeutic response to the medication. Which phase
of the nursing process do these actions illustrate?
A. Nursing diagnosis
B. Planning
C. Implementation
D. Evaluation
Ans: d
Monitoring the patient‘s progress, including the patient‘s response to the medication, is part of
the evaluation phase. Planning, implementation, and nursing diagnosis are not illustrated by
this example.
Dif: cognitive level: understanding (comprehension) top: nursing process: evaluation
Msc: nclex: safe and effective care environment: management of care
4. The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes mellitus.
Which statement best illustrates an outcome criterion for this patient?
A. The patient will follow instructions.
B. The patient will not experience complications.
C. The patient will adhere to the new insulin treatment regimen.
